Minireview: Invasive fungal infection complicating acute Plasmodium falciparum malaria

Mycoses

Volumn 54, Issue 4, 2011, Pages 311-317

  Däbritz, Jan ^a,b   Schneider, Markward ^c   Just Nuebling, Gudrun ^d   Groll, Andreas H ^b,c  

^a Department of General Pediatrics ^*  (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Senckenberg's Department of Pathology   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Aspergillosis; Candidiasis; Malaria; Plasmodium falciparum; Zygomycosis

Indexed keywords

ANTIBIOTIC AGENT; CHLOROQUINE; DEXAMETHASONE; MEFLOQUINE; QUININE;

ACIDOSIS; ADAPTIVE IMMUNITY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AUTOPSY; BLOOD CLOTTING DISORDER; CASE REPORT; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; DISSEMINATED HYALOHYPHOMYCOSIS; DYSPNEA; FEMALE; FEVER; FLU LIKE SYNDROME; HEART ARREST; HEART FAILURE; HEMOLYSIS; HUMAN; HYALOHYPHOMYCOSIS; INFECTION SENSITIVITY; INNATE IMMUNITY; INTENSIVE CARE; KIDNEY FAILURE; MALARIA FALCIPARUM; MEDICAL LITERATURE; OPPORTUNISTIC INFECTION; OXYGEN SUPPLY; PRIORITY JOURNAL; RESPIRATORY ARREST; REVIEW; SYSTEMIC MYCOSIS; THROMBOCYTOPENIA; TISSUE INJURY; TRAVEL;

BRAIN; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY; LIVER; LUNG; MALARIA, FALCIPARUM; MICROSCOPY; MYCOSES; MYOCARDIUM; PLASMODIUM FALCIPARUM; TRACHEA;

BACTERIA (MICROORGANISMS); PLASMODIUM FALCIPARUM;

EID: 79955050021     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01826.x     Document Type: Review

References (59)

1. Greenwood BM, Bojang K, Whitty CJ, Targett GA. Malaria. Lancet 2005; 365: 1487-98.
2. Muentener P, Schlagenhauf P, Steffen R. Imported malaria (1985-95): trends and perspectives. Bull World Health Organ 1999; 77: 560-6.
3. Schoeneberg I, Apitsch I, Rasch G. Malaria cases and death in Germany from 1993 to 1997. Gesundheitswesen 1998; 60: 755-61.
4. European Network on Imported Infectious Disease Surveillance. TropNetEurop Friends & Oberservers Sentinel Surveillance Report: January/February 2008, Malaria in 2007. Available from: [Accessed 12 November 2009].
5. Robert-Koch-Institute. Robert-Koch-Institute: Epidemiological Bulletin 41/2007. Available from [Accessed 12 November 2009].
6. Bruneel F, Tubach F, Corne P, Megarbane B, Mathonnet A, Wolff M. Severe imported malaria: a multicenter study in 400 adults. In: Abstracts of the 4th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, USA: American Society for Microbiology, 2008: 2945.
7. Weidanz WP. Malaria and alterations in immune reactivity. Br Med Bull 1982; 38: 167-72.
8. Bearman GM, Munro C, Sessler CN, Wenzel RP. Infection control and the prevention of nosocomial infections in the intensive care unit. Semin Respir Crit Care Med 2006; 27: 310-24.
9. Hocqueloux L, Bruneel F, Pages CL, Vachon F. Fatal invasive aspergillosis complicating severe Plasmodium falciparum malaria. Clin Infect Dis 2000; 30: 940-2.
10. Ruhnke M, Eichenauer E, Searle J, Lippek F. Fulminant tracheobronchial and pulmonary aspergillosis complicating imported Plasmodium falciparum malaria in an apparently immunocompetent woman. Clin Infect Dis 2000; 30: 938-40.
11. Wilson AP, Wright S, Bellingan G. Disseminated fungal infection following falciparum malaria. J Infect 2000; 40: 202-4.
12. Eckerle I, Ebinger D, Gotthardt D et al. Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature. Malar J 2009; 8: 167.
13. Spitz S. The pathology of acute falciparum malaria. Mil Surg 1946; 99: 555-72.
14. Warrell DA, Looareesuwan S, Warrell MJ et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med 1982; 306: 313-9.
15. Horstmann RD, Ehrich JH, Beck J, Dietrich M. Fatal complications of tropical malaria in non-immune patients. A retrospective clinico-pathologic analysis of 25 cases. Dtsch Med Wochenschr 1985; 110: 1651-6.
16. Mirdha BR, Sarkar T, Banerjee U, Sethi S, Dan G, Xess I. Concurrent cryptococcal meningitis and falciparum malaria in a child with nephrotic syndrome. Indian Pediatr 1998; 35: 360-3.
17. Ashiru JO, Akang EE. Cryptococcal meningitis with malaria. A case report. Mycopathologia 1994; 27: 5-7.
18. Soesan M, Kager PA, Leverstein-van Hall MA, van Lieshout JJ. Coincidental severe Plasmodium falciparum infection and disseminated candidiasis. Trans R Soc Trop Med Hyg 1993; 87: 288-9.
19. Méan M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 2008; 12: 204.
20. Roilides E, Dignani MC, Anaissie EJ, Rex JH. The role of immunoreconstitution in the management of refractory opportunistic fungal infections. Med Mycol 1998; 36(Suppl 1): 12-25.
21. Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol 2005; 129: 569-82.
22. Segal BH, Kwon-Chung J, Walsh TJ et al. Immunotherapy for fungal infections. Clin Infect Dis 2006; 42: 507-15.
23. Field JW. Blood examination and prognosis in acute falciparum malaria. Trans R Soc Trop Med Hyg 1949; 43: 33-48.
24. Dudgeon LS, Clarke C. A contribution to the microscopical histology of malaria. Lancet 1917; II: 153-6.
25. Heinemann HS. The clinical syndrome of malaria in the United States. Arch Intern Med 1972; 129: 607-16.
26. Neva FA, Sheagren JN, Shulman NR, Canfield CJ. Malaria: host-defense mechanisms and complications. Ann Intern Med 1970; 73: 295-306.
27. Stone WJ, Hanchett JE, Knepshield JH. Acute renal insufficiency due to falciparum malaria. Review of 42 cases. Arch Intern Med 1972; 129: 620-8.
28. Chen Q, Schlichtherle M, Wahlgren M. Molecular aspects of severe malaria. Clin Microbiol Rev 2000; 13: 439-50.
29. Boelaert JR, de Locht M, Van Cutsem J et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. J Clin Invest 1993; 91: 19790-860.
30. Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 2006; 55: 251-8.
31. Calderone R, Suzuki S, Cannon R et al. Candida albicans: adherence, signaling and virulence. Med Mycol 2000; 38(Suppl 1): 125-37.
32. Ibrahim AS, Edwards JE Jr, Fu Y, Spellberg B. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 2006; 58: 1070-3.
33. Jung WH, Kronstad JW. Iron and fungal pathogenesis: a case study with Cryptococcus neoformans. Cell Microbiol 2008; 10: 277-84.
34. Mencacci A, Cenci E, Boelaert JR et al. Iron overload alters innate and T helper cell responses to Candida albicans in mice. J Infect Dis 1997; 175: 1467-76.
35. Kontoyiannis DP, Chamilos G, Lewis RE et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007; 110: 1303-6.
36. Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley KV. Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl 2006; 12: 1799-804.
37. Tramsen L, Beck O, Schuster FR et al. Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant. J Infect Dis 2007; 196: 485-92.
38. Beck O, Topp MS, Koehl U et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006; 107: 2562-9.
39. Whittle HC, Brown J, Marsh K et al. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 1984; 312: 449-50.
40. Kremsner PG, Zotter GM, Feldmeier H et al. Immune response in patients during and after Plasmodium falciparum infection. J Infect Dis 1990; 161: 1025-8.
41. Ho M, Webster HK. T cell responses in acute falciparum malaria. Immunol Lett 1990; 25: 135-8.
42. Fiori PL, Rappelli P, Mirkarimi SN, Ginsburg H, Cappuccinelli P, Turrini F. Reduced microbicidal and anti-tumour activities of human monocytes after ingestion of Plasmodium falciparum-infected red blood cells. Parasite Immunol 1993; 15: 647-55.
43. Urban BC, Ferguson DJ, Pain A et al. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999; 400: 73-77.
44. Enwere GC, Ota MO, Obaro SK. The host response in malaria and depression of defence against tuberculosis. Ann Trop Med Parasitol 1999; 93: 669-78.
45. Romani L. Cell mediated immunity to fungi: a reassessment. Med Mycol 2008; 12: 1-15.
46. Urban BC, Roberts DJ. Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells. Curr Opin Immunol 2002; 14: 458-65.
47. Urban BC, Todryk S. Malaria pigment paralyzes dendritic cells. J Biol 2006; 5: 4.
48. Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 5: 722-35.
49. Schwarzer E, De Matteis F, Giribaldi G, Ulliers D, Valente E, Arese P. Hemozoin stability and dormant induction of heme oxygenase in hemozoin-fed human monocytes. Mol Biochem Parasitol 1999; 100: 61-72.
50. Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp Med 1992; 176: 1033-41.
51. Schwarzer E, Alessio M, Ulliers D, Arese P. Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes. Infect Immun 1998; 66: 1601-6.
52. Scorza T, Magez S, Brys L, De Baetselier P. Hemozoin is a key factor in the induction of malaria-associated immunosuppression. Parasite Immunol 1999; 21: 545-54.
53. Leitner WW, Krzych U. Plasmodium falciparum malaria blood stage parasites preferentially inhibit macrophages with high phagocytic activity. Parasite Immunol 1997; 19: 103-10.
54. Skorokhod OA, Alessio M, Mordmüller B, Arese P, Schwarzer E. Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect. J Immunol 2004; 173: 4066-74.
55. Millington OR, Di Lorenzo C, Phillips RS, Garside P, Brewer JM. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol 2006; 5: 5.
56. Britt RC, Devine A, Swallen KC et al. Corticosteroid use in the intensive care unit: at what cost? Arch Surg 2006; 141: 145-9.
57. Dale DC, Petersdorf RG. Corticosteroids and infectious diseases. Med Clin North Am 1973; 57: 1277-87.
58. Fryauff DJ, Church LW, Richards AL et al. Lymphocyte response to tetanus toxoid among Indonesian men immunized with tetanus-diphtheria during extended chloroquine or primaquine prophylaxis. J Infect Dis 1997; 176: 1644-8.
59. Nishimura M, Hidaka N, Akaza T, Tadokoro K, Juji T. Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease. Transfus Med 1998; 8: 209-14.